Avance Clinical Expands In Asia With Taipei Office To Accelerate Biotech Clinical Trials

Avance Clinical, the award-winning, full-service Contract Research Organization (CRO) specializing in delivering agile and accelerated clinical development solutions for global biotechs, has further strengthened its presence in Asia with the opening of an office in Taipei, Taiwan.

This expansion enhances Avance Clinical’s ability to support global biotechs with seamless early-to-late-phase clinical trial execution, leveraging Asia’s rapid regulatory pathways, high-quality data, and diverse patient populations.

CEO Yvonne Lungershausen said, “This expansion to Taiwan reflects our commitment to supporting biotechs on their global clinical development journey, ensuring a smooth transition across regions. Taiwan offers world-class trial sites with highly skilled investigators, reinforcing our ability to deliver top-tier clinical research for global biotechs.”

Joe Taouk, Vice President, Global Project Delivery, emphasized, “Taiwan is a vital addition to our Asia-Pacific operations, offering global biotechs streamlined access to top-tier clinical trials. This is just the beginning, with our presence now established in South Korea and Taiwan, our eyes are set on further expansion across the region providing an even boarder offering for our clients.”

To lead operations in Taiwan, Avance Clinical has appointed Kelly Yang as Associate Director of Operations. With over 15 years of experience in the pharmaceutical and clinical research industries, Yang will develop a high-performance local operations team and build a robust Avance Clinical Global Site Partnership Network. This initiative aims to provide sponsors with accelerated and high-quality trial outcomes, competitive timelines, and cost-effective solutions.

“With a skilled clinical workforce and streamlined regulatory pathways, Taiwan provides global biotechs with local expertise and support in Taiwan”, said Yang. “Its high-density population enables efficient patient access, making it an ideal location for clinical research. We are excited to expand our presence here and offer global biotech companies seamless access to Asia’s clinical trial ecosystem.”

Taiwan’s inclusion aligns with Avance Clinical’s Asia Advantage strategy, offering benefits such as diverse patient populations, FDA- and EMA-accepted data, and established site networks. The expansion further enhances the company’s ability to deliver end-to-end trial support from early-phase studies in Australia to late-phase trials in Asia and the US.

About Avance Clinical

Avance Clinical is a leading Contract Research Organization (CRO) delivering faster, more flexible, and high-quality clinical trial services. As the largest premium full-service CRO headquartered in Australia, Avance Clinical provides globally accepted data for international biotechs across Australia, New Zealand, Asia, North America, and Europe. With 30 years of experience and expertise spanning 250+ indications, the company offers comprehensive support from early to late-phase trials.